Source: https://www.law.cornell.edu/cfr/text/38/4.115b
Timestamp: 2015-03-05 08:33:52
Document Index: 110531300

Matched Legal Cases: ['art 4', '§ 4', '§ 3', '§ 3', '§ 4', '§ 4', '§ 3', '§ 3']

38 CFR 4.115b - Ratings of the genitourinary system | LII / Legal Information Institute
CFR › Title 38 › Chapter I › Part 4 › Subpart B › Section 4.115b 38 CFR 4.115b - Ratings of the genitourinary system
§ 4.115b
1 Review for entitlement to special monthly compensation under § 3.350 of this chapter.
Note: When evaluating any claim involving loss or loss of use of one or more creative organs, refer to § 3.350 of this chapter to determine whether the veteran may be entitled to special monthly compensation. Footnotes in the schedule indicate conditions which potentially establish entitlement to special monthly compensation; however, there are other conditions in this section which under certain circumstances also establish entitlement to special monthly compensation.
7500Kidney, removal of one:
7501Kidney, abscess of:
7502Nephritis, chronic:
7504Pyelonephritis, chronic:
7505Kidney, tuberculosis of:
Rate in accordance with §§ 4.88b or 4.89, whichever is appropriate.
7507Nephrosclerosis, arteriolar:
7508Nephrolithiasis:
7509Hydronephrosis:
7510Ureterolithiasis:
7511Ureter, stricture of:
7512Cystitis, chronic, includes interstitial and all etiologies, infectious and non-infectious:
7515Bladder, calculus in, with symptoms interfering with function:
7516Bladder, fistula of:
Postoperative, suprapubic cystotomy
7517Bladder, injury of:
7518Urethra, stricture of:
7519Urethra, fistual of:
Multiple urethroperineal fistulae
7520Penis, removal of half or more
7521Penis removal of glans
7522Penis, deformity, with loss of erectile power—20 1
7523Testis, atrophy complete:
Both—20 1
One—0 1
7524Testis, removal:
Both—30 1
7525Epididymo-orchitis, chronic only:
For tubercular infections: Rate in accordance with §§ 4.88b or 4.89, whichever is appropriate.
7527Prostate gland injuries, infections, hypertrophy, postoperative residuals:
7528Malignant neoplasms of the genitourinary system
Note—Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.
7529Benign neoplasms of the genitourinary system:
7530Chronic renal disease requiring regular dialysis:
7531Kidney transplant:
Thereafter: Rate on residuals as renal dysfunction, minimum rating
Note—The 100 percent evaluation shall be assigned as of the date of hospital admission for transplant surgery and shall continue with a mandatory VA examination one year following hospital discharge. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter.
7532Renal tubular disorders (such as renal glycosurias, aminoacidurias, renal tubular acidosis, Fanconi's syndrome, Bartter's syndrome, related disorders of Henle's loop and proximal or distal nephron function, etc.):
Minimum rating for symptomatic condition
7533Cystic diseases of the kidneys (polycystic disease, uremic medullary cystic disease, Medullary sponge kidney, and similar conditions):
7534Atherosclerotic renal disease (renal artery stenosis or atheroembolic renal disease):
7535Toxic nephropathy (antibotics, radiocontrast agents, nonsteroidal anti-inflammatory agents, heavy metals, and similar agents):
7536Glomerulonephritis:
7537Interstitial nephritis:
7538Papillary necrosis:
7539Renal amyloid disease:
7540Disseminated intravascular coagulation with renal cortical necrosis:
7541Renal involvement in diabetes mellitus, sickle cell anemia, systemic lupus erythematosus, vasculitis, or other systemic disease processes.
7542Neurogenic bladder: